Millennium Pharmacon Financials
| SDPC Stock | IDR 158.00 15.00 8.67% |
Millennium |
Understanding current and past Millennium Pharmacon Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Millennium Pharmacon's financial statements are interrelated, with each one affecting the others. For example, an increase in Millennium Pharmacon's assets may result in an increase in income on the income statement.
Millennium Pharmacon Stock Summary
Millennium Pharmacon competes with Astra Graphia, Hexindo Adiperkasa, Lautan Luas, and Citra Marga. PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000072804 |
| Business Address | Crown Bungur Arteri, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.mpi-indonesia.co.id |
| Phone | 62 21 270 85961 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Millennium Pharmacon without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Millennium Stock, because this is throwing your money away. Analyzing the key information contained in Millennium Pharmacon's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Millennium Pharmacon Key Financial Ratios
Millennium Pharmacon's financial ratios allow both analysts and investors to convert raw data from Millennium Pharmacon's financial statements into concise, actionable information that can be used to evaluate the performance of Millennium Pharmacon over time and compare it to other companies across industries.| Return On Equity | 0.0938 | |||
| Return On Asset | 0.0342 | |||
| Beta | 0.75 | |||
| Last Dividend Paid | 1.0 |
Millennium Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Millennium Pharmacon's current stock value. Our valuation model uses many indicators to compare Millennium Pharmacon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Millennium Pharmacon competition to find correlations between indicators driving Millennium Pharmacon's intrinsic value. More Info.Millennium Pharmacon International is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.36 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Millennium Pharmacon International is roughly 2.74 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Millennium Pharmacon's earnings, one of the primary drivers of an investment's value.Millennium Pharmacon Systematic Risk
Millennium Pharmacon's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Millennium Pharmacon volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Millennium Pharmacon correlated with the market. If Beta is less than 0 Millennium Pharmacon generally moves in the opposite direction as compared to the market. If Millennium Pharmacon Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Millennium Pharmacon is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Millennium Pharmacon is generally in the same direction as the market. If Beta > 1 Millennium Pharmacon moves generally in the same direction as, but more than the movement of the benchmark.
Millennium Pharmacon November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Millennium Pharmacon help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Millennium Pharmacon International. We use our internally-developed statistical techniques to arrive at the intrinsic value of Millennium Pharmacon International based on widely used predictive technical indicators. In general, we focus on analyzing Millennium Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Millennium Pharmacon's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.4 | |||
| Information Ratio | 0.0549 | |||
| Maximum Drawdown | 22.69 | |||
| Value At Risk | (3.55) | |||
| Potential Upside | 5.88 |
Other Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.